Methylated B vitamins, chiefly methylfolate and methylcobalamin, are sold at a premium on the argument that they arrive pre-activated and bypass a conversion step that some people perform poorly. The genetics behind the claim are real. The conclusion drawn from them is considerably shakier.
What is the conversion being bypassed?
Folic acid, the synthetic form used in supplements and fortification, must be converted through several steps into 5-methyltetrahydrofolate, the form circulating in blood. One of those steps uses an enzyme called MTHFR.
Methylfolate is that end product supplied directly. Methylcobalamin is similarly one of the active forms of B12, as opposed to cyanocobalamin, which the body converts.
What does the MTHFR variant do?
The most discussed variant is C677T. People with two copies have reduced enzyme activity, commonly cited as around 30 per cent of normal, and tend to show modestly higher homocysteine and slightly lower folate levels.
These variants are common. Roughly 10 per cent of people of European descent carry two copies, and rates vary considerably between populations.
Something present in a tenth of the population is a normal human variation. Large studies have generally not found that carriers suffer meaningfully worse health outcomes, and adequate folate intake normalises homocysteine in carriers just as it does in others.
Does folic acid work in people with the variant?
Generally yes. Trials have shown that ordinary folic acid raises blood folate and lowers homocysteine effectively in people with the C677T variant.
Reduced enzyme activity is not absent enzyme activity. The pathway runs more slowly and still runs, and at the intakes involved that is usually sufficient.
The strongest evidence for folic acid specifically comes from neural tube defect prevention, where trials used folic acid rather than methylfolate. That is a substantial argument for not abandoning the well studied form during pregnancy.
Is there an argument for methylfolate?
There is a reasonable one, though narrower than the marketing suggests. Unmetabolised folic acid appears in blood when intake is high, and the long term significance of that is not fully understood.
Methylfolate avoids that, and some clinicians prefer it in specific contexts, including certain psychiatric prescribing where high dose methylfolate has been studied as an antidepressant adjunct.
There is also a practical downside. Some people report feeling anxious or irritable on methylfolate, particularly at higher doses, and the reason is not well established.
What about methylcobalamin?
The argument here is weaker still. Converting cyanocobalamin to active B12 forms involves different enzymes entirely, so MTHFR is irrelevant to it.
Studies comparing the forms have found them broadly comparable for correcting deficiency. Cyanocobalamin is cheaper, more stable in storage, and is what most of the clinical research used.
Should you get tested for MTHFR?
Routine testing is not recommended by genetics or haematology bodies, on the grounds that the result does not change management for most people.
Direct to consumer genetic tests report these variants frequently, and a result showing a common variant is often presented as a finding requiring action. In most cases it does not.
If you have a personal or family history of recurrent blood clots or recurrent miscarriage, that is a matter to raise with a doctor rather than to address with a supplement.
What is the practical conclusion?
For most people, ordinary folic acid and cyanocobalamin work perfectly well and cost far less. If you are planning pregnancy, folic acid is what the trials used and what guidance specifies.
Methylated forms are not worse, simply more expensive without clear added benefit for most users. If a clinician has advised them for a specific reason, follow that advice rather than substituting on price.
It is worth being wary of any supplement sold primarily on the strength of a genetic variant that a tenth of the population carries. The marketing works by converting a common and largely unremarkable finding into a personal problem requiring a specific product.
This article is general information and not medical advice.